SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,624,000 | -16.8% | 216,500 | 0.0% | 0.05% | -10.3% |
| Q3 2021 | $1,951,000 | -24.7% | 216,500 | 0.0% | 0.06% | -26.6% |
| Q2 2021 | $2,592,000 | -4.5% | 216,500 | 0.0% | 0.08% | -7.1% |
| Q1 2021 | $2,713,000 | -19.7% | 216,500 | 0.0% | 0.08% | -26.1% |
| Q4 2020 | $3,378,000 | -14.2% | 216,500 | -48.0% | 0.12% | -28.6% |
| Q3 2020 | $3,936,000 | +5.5% | 416,500 | 0.0% | 0.16% | -1.2% |
| Q2 2020 | $3,732,000 | +40.7% | 416,500 | 0.0% | 0.16% | +11.6% |
| Q1 2020 | $2,653,000 | -23.9% | 416,500 | 0.0% | 0.15% | 0.0% |
| Q4 2019 | $3,486,000 | -7.5% | 416,500 | 0.0% | 0.15% | -10.4% |
| Q3 2019 | $3,769,000 | -16.0% | 416,500 | 0.0% | 0.16% | -21.6% |
| Q2 2019 | $4,486,000 | +12.9% | 416,500 | 0.0% | 0.21% | +13.7% |
| Q1 2019 | $3,973,000 | -8.9% | 416,500 | +9.6% | 0.18% | -12.4% |
| Q4 2018 | $4,362,000 | -17.0% | 380,000 | +22.6% | 0.21% | -12.2% |
| Q3 2018 | $5,255,000 | +42.3% | 310,000 | +19.2% | 0.24% | +63.0% |
| Q2 2018 | $3,692,000 | -7.5% | 260,000 | +23.8% | 0.15% | -9.3% |
| Q1 2018 | $3,990,000 | -30.5% | 210,000 | -40.0% | 0.16% | -26.8% |
| Q4 2017 | $5,740,000 | -29.1% | 350,000 | -35.2% | 0.22% | -28.1% |
| Q3 2017 | $8,100,000 | +58.7% | 540,000 | -6.9% | 0.31% | +66.3% |
| Q2 2017 | $5,104,000 | +55.8% | 580,000 | -7.9% | 0.18% | +65.8% |
| Q1 2017 | $3,276,000 | +70.4% | 630,000 | 0.0% | 0.11% | +56.3% |
| Q4 2016 | $1,922,000 | -34.1% | 630,000 | 0.0% | 0.07% | -33.6% |
| Q3 2016 | $2,917,000 | +0.8% | 630,000 | +26.0% | 0.11% | +30.5% |
| Q2 2016 | $2,895,000 | -4.3% | 500,000 | 0.0% | 0.08% | -3.5% |
| Q1 2016 | $3,025,000 | -32.4% | 500,000 | +2.0% | 0.08% | -26.7% |
| Q4 2015 | $4,474,000 | +61.9% | 490,000 | 0.0% | 0.12% | +81.2% |
| Q3 2015 | $2,764,000 | -26.7% | 490,000 | +44.1% | 0.06% | -16.9% |
| Q2 2015 | $3,771,000 | -29.3% | 340,000 | 0.0% | 0.08% | -33.6% |
| Q1 2015 | $5,331,000 | +3.1% | 340,000 | 0.0% | 0.12% | +8.4% |
| Q4 2014 | $5,171,000 | +41.0% | 340,000 | 0.0% | 0.11% | +55.1% |
| Q3 2014 | $3,667,000 | -29.4% | 340,000 | 0.0% | 0.07% | -24.2% |
| Q2 2014 | $5,192,000 | +19.7% | 340,000 | +41.7% | 0.09% | +21.3% |
| Q1 2014 | $4,339,000 | +11.6% | 240,000 | -14.3% | 0.08% | +10.3% |
| Q4 2013 | $3,889,000 | +54.4% | 280,000 | +16.7% | 0.07% | +58.1% |
| Q3 2013 | $2,518,000 | +34.4% | 240,000 | 0.0% | 0.04% | +34.4% |
| Q2 2013 | $1,874,000 | – | 240,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |